세계의 당뇨병 관리 기기 시장

The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.

The global market for continuous glucose monitoring systems is expected to grow from $11.1 billion in 2024 to $20.9 billion by the end of 2029, at a CAGR of 13.4% from 2024 through 2029.

The global market for self-monitoring blood glucose devices is expected to grow from $5.5 billion in 2024 to $5.9 billion by the end of 2029, at a CAGR of 1.7% from 2024 through 2029.

Report Scope

This report provides an analysis of the market for diabetes monitoring devices, along with a competitive landscape and profiles of key companies that include their revenues, product portfolios and recent activities. It analyzes trends and market dynamics, including drivers, limitations, challenges, and opportunities, and discusses historical, current and potential market size. The report will enable readers to make informed decisions about the production and licensing of goods and services, as well as market developments and trends. The study segments the market by product type, including self-monitoring blood glucose (SMBG) devices such as blood glucose meter devices, blood glucose test strips, lancets and lancet devices; and continuous glucose monitoring (CGM) device products, including transmitters and receivers. A regional market analysis, including country-level analysis, is provided for all segments. The report covers only diabetes monitoring devices; diabetes therapeutic devices, which include insulin delivery systems and any other equipment used in hospitals are outside the scope of the report.

Self-monitoring blood glucose (SMBG) devices:

• Blood glucose meter devices.
• Blood glucose test strips.
• Lancets and lancet devices.

Continuous glucose monitoring (CGM) systems:

• Sensors and transmitters.
• Receivers.

End users:

• Hospitals.
• Home care settings.
• Diagnostic centers.

Report Includes:

• 30 data tables and 47 additional tables
• An analysis of the global market for diabetes care devices, including self-glucose monitoring devices and continuous glucose monitoring systems
• Analyses of the global market trends, with market revenue data (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type and sub-type, end user and region
• Discussion of the market potential and opportunities in the diabetes care industry, along with an analysis of the competitive environment, regulatory scenario and technological advances
• Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Patent analysis featuring key granted and published patents
• Emerging new developments and clinical trials in the diabetes care market
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Abbott, Medtronic, Dexcom Inc., F. Hoffmann-La Roche Ltd., and LifeScan IP Holdings LLC.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Market Definitions
• Diabetes Mellitus
• Types of Diabetes
• Self-Monitoring Diabetic Care Devices

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Prevalence of Diabetes
• Increasing Aging Population
• Demand for Better Personal Diabetes Management Tools
• Healthcare and Reimbursement Policies
• Increasing Focus on Preventive Healthcare
• Market Restraints
• Lack of Continuous Data
• High Cost of CGMs
• Limited Access in Low-Income Regions
• Opportunities in the Market
• Need for Diabetes Management Solutions
• Partnerships
• Market Challenges
• Lack of Glucose Meter and CGM Accuracy

Chapter 4 Emerging Technologies and Developments

• Overview
• Implantable CGM Technology
• AI Integration in CGM Monitoring
• Non-Invasive CGM System
• Clinical Trials

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Global Market for Diabetes Monitoring Devices, by Type
• Self-Monitoring Blood Glucose (SMBG) Devices
• Continuous Glucose Monitoring (CGM) Systems
• Geographic Breakdown
• Global Market for Diabetes Monitoring Devices, by Region
• North America
• Europe
• Asia-Pacific
• South America
• Rest of the World

Chapter 6 Competitive Intelligence

• Industry Scenario
• Competitive Landscape

Chapter 7 Sustainability in the Diabetic Care Devices Market: An ESG Perspective

• Introduction to ESG
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 8 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• ABBOTT
• ACON LABORATORIES INC.
• AGAMATRIX
• ARKRAY INC.
• B. BRAUN SE
• DEXCOM INC.
• F. HOFFMANN-LA ROCHE LTD.
• I-SENS INC.
• LIFESCAN IP HOLDINGS LLC.
• MEDTRONIC
• PHC HOLDINGS CORP.
• SENSEONICS
• SINOCARE
• TERUMO CORP.
• YPSOMED